‘Game changer’: Infectious disease doc believes hydroxychloroquine is ‘beginning of the end’ of pandemic

[sharenow]
(Fox News video screenshot)

An infectious disease specialist has unveiled new data that suggests hydroxychloroquine is indeed the miracle coronavirus cure that so many across the globe need right now.

Speaking on Fox News’ “The Ingraham Angle” late Wednesday, Dr. Stephen Smith revealed that of the patients he’s treated at the Smith Center for Infectious Diseases in New Jersey, not a single one who was treated with hydroxychloroquine required intubation with a ventilator.

“[N]o person [who] has received five days or more of the hydroxychloroquine combination has been intubated,” he explained. “The chance of that occurring by chance … are .000 something. It’s ridiculously low, no matter how you look at it.”

“You worry about selection bias in the situation, but I cannot think of a reason why, if all else is equal, why people that have received five days or more of this hydroxychloroquine wouldn’t get intubated.”

Listen (disable your adblocker if the video doesn’t appear):


(Source: Fox News)

It’s absolutely a game-changer,” he added. “I think this data really supports the French data … saying that this regimen works.”

“Laura, I think this is the beginning of the end. Of the pandemic,” he emphasized before Ingraham moved on from the segment.

A French study found that a combination of hydroxychloroquine and the antibiotic azithromycin works wonders in treating coronavirus patients.

However, the study has been dismissed by a cynical left-wing mainstream establishment that seems more interested in ginning up endless fear and terror for clicks and money than in finding a remedy for a virus that’s infecting people left and right.

And so despite a growing body of evidence in favor of hydroxychloroquine’s usage to treat the coronavirus, some left-wing state officials have banned its use, thus leaving their constituents with no viable way to fight back against the virus.

These actions have enraged those who believe that coronavirus patients who face potential death deserve the option to try any treatment available to them.

As it stands, hydroxychloroquine is so potent that doctors here and abroad are themselves personally “taking a 5 to 10 day course of hydroxychloroquine” as a “go-to prophylactic,” according to FNC’s host Laura Ingraham:

With results like this, she added in an additional tweet, it just doesn’t make sense why President Donald Trump hasn’t issued an executive order yet mandating hydroxychloroquine be mass-manufactured:

Especially given how many Americans are at risk of facing serious complications from the coronavirus.

Earlier on “The Ingraham Angle” late Wednesday, Smith also unveiled data showing that pre-diabetic, diabetic and obese patients are at higher risk for “severe rapid COVID disease,” which is what causes a need for intubation.

His data fits with what was unveiled in the Centers for Disease Control and Prevention’s latest Morbidity and Mortality Weekly Report.

“People with chronic conditions like diabetes and lung and heart disease are at greater risk of being hospitalized due to the coronavirus – but more than one in five patients who end up in intensive care had no such health problems, according to a report,” the New York Post reported Wednesday.

“Higher percentages of patients with such underlying conditions have been admitted to hospitals. … Preliminary data from 7,162 patients show that 37.6 percent had one or more underlying medical conditions.”

Listen to the first part of Smith’s discussion with Ingraham below:

All this comes as more and more medical institutions have begun adopting hydroxychloroquine as a viable coronavirus treatment, including the Henry Ford Health System in Detroit.

“Henry Ford Health System says it’s been using the drug hydroxychloroquine to treat severe cases of COVID-19 in hospitalized patients,” Michigan Radio confirmed Tuesday.

“Dr. Marcus Zervos is an infectious disease specialist at Henry Ford. He says staff at Henry Ford has been using hydroxychloroquine to treat the most severe cases of COVID-19 in hospitalized patients.”

According to Zervos, the treatments have been successful.

“What we know about the drug now is that it does reduce viral shedding, you know, the amount of virus a person has, it’s lower,” he said. “There have been studies from China to show that patients have shorter hospitalizations, fewer complications, lower likelihood of progression.”

However, Zervos pushed back on the idea that it could be a miracle cure.

“I don’t want to give the idea that hydroxychloroquine is the only treatment, or is going to be some sort of a miracle cure,” he said. “Really, that still has to be looked at in a formal, clinical trial, we still need more data.”

“We are in a very difficult situation right now where we have to do our best to do whatever we can to prevent complications and prevent patients from going into intensive care units and death. We feel this is an important option, but there may be other options that are better, that are able to address the issue.”

Perhaps, but for now, far too many lives are at stake for anyone, including him, to dither.

DONATE TO BIZPAC REVIEW

Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

Success! Thank you for donating. Please share BPR content to help combat the lies.
[sharenow]
Vivek Saxena

Comment

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.

PLEASE JOIN OUR NEW COMMENT SYSTEM! We love hearing from our readers and invite you to join us for feedback and great conversation. If you've commented with us before, we'll need you to re-input your email address for this. The public will not see it and we do not share it.

Latest Articles